9 meters Biopharma announces deal for Phase 3 trial of celiac disease treatment | Seeking Alpha

Retrieved on: 2022-04-20 16:36:27

Tags for this article:

Medical specialties

Gluten sensitivity

Non-celiac gluten sensitivity

Coeliac disease

Wheat allergy

Gastrointestinal tract

Gluten-related disorders

Gluten challenge test

Click the tags to see associated articles and topics

9 meters Biopharma announces deal for Phase 3 trial of celiac disease treatment | Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/news/3824816-9-meters-biopharma-announces-deal-for-phase-3-trial-of-celiac-disease-treatment%3Fsource%3Dfeed_sector_healthcare

Excerpt

9 Meters Biopharma (NMTR) said on Wednesday it had tied-up with Celiac.com, a website for gluten-free diet due to celiac disease, to help support ...

Article found on: seekingalpha.com

View Original Article